US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist
  • 6.880
  • -0.250-3.51%
Close Dec 13 16:00 ET
  • 6.880
  • 0.0000.00%
Post 20:01 ET
227.49MMarket Cap-2.63P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexeo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Lexeo Therapeutics Earnings Reports

  • Lexeo Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 07:38 ET

  • Lexeo Therapeutics | 8-K: Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results

    Nov 13 07:33 ET

  • Lexeo Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 07:05 ET

  • Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights

    Aug 12 07:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data